Edition:
United Kingdom

AtriCure Inc (ATRC.OQ)

ATRC.OQ on NASDAQ Stock Exchange Global Market

26.42USD
23 Aug 2019
Change (% chg)

$-0.28 (-1.05%)
Prev Close
$26.70
Open
$26.57
Day's High
$27.15
Day's Low
$26.35
Volume
111,328
Avg. Vol
75,237
52-wk High
$36.08
52-wk Low
$26.15

Latest Key Developments (Source: Significant Developments)

AtriCure Reports Q2 Adjusted Loss Per Share $0.17
Tuesday, 30 Jul 2019 

July 30 (Reuters) - AtriCure Inc ::REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 ADJUSTED LOSS PER SHARE $0.17.Q2 LOSS PER SHARE $0.11.Q2 REVENUE $58.9 MILLION VERSUS REFINITIV IBES ESTIMATE OF $57.8 MILLION.Q2 EARNINGS PER SHARE ESTIMATE $-0.18 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE $224 MILLION TO $228 MILLION.  Full Article

Atricure Reports Q1 Adj Loss Per Share Of $0.20
Thursday, 25 Apr 2019 

April 25 (Reuters) - AtriCure Inc ::REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 ADJUSTED LOSS PER SHARE $0.20.Q1 LOSS PER SHARE $0.15.Q1 REVENUE $54 MILLION VERSUS REFINITIV IBES ESTIMATE OF $52.5 MILLION.Q1 EARNINGS PER SHARE ESTIMATE $-0.24 -- REFINITIV IBES DATA.SEES FY 2019 REVENUE $222 MILLION TO $228 MILLION.INC - MAINTAINING EXPECTATIONS FOR POSITIVE FULL-YEAR ADJUSTED EBITDA BETWEEN $0 AND $3 MILLION.  Full Article

Atricure Inc Files For Potential Mixed Shelf Offering
Friday, 1 Mar 2019 

March 1 (Reuters) - AtriCure Inc ::ATRICURE INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING.ATRICURE INC - ALSO, SELLING SECURITYHOLDERS MAY, FROM TIME TO TIME, OFFER AND SELL UP TO AN ADDITIONAL 5.7 MILLION SHARES OF CO'S COMMON STOCK.  Full Article

Atricure Inc Q1 Loss Per Share $0.31
Thursday, 26 Apr 2018 

April 26 (Reuters) - AtriCure Inc ::REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.31.Q1 REVENUE $47 MILLION VERSUS I/B/E/S VIEW $45.5 MILLION.SEES FY 2018 REVENUE ABOUT $190 MILLION TO $196 MILLION.Q1 EARNINGS PER SHARE VIEW $-0.27 -- THOMSON REUTERS I/B/E/S.  Full Article

Atricure Posts Q4 Loss Per Share $0.08
Monday, 26 Feb 2018 

Feb 26 (Reuters) - Atricure Inc ::ATRICURE REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS.Q4 LOSS PER SHARE $0.08.Q4 REVENUE $46.1 MILLION.SEES FY 2018 REVENUE ABOUT $190 MILLION TO $196 MILLION.‍ PROJECTS 2018 ADJUSTED EBITDA, A NON-GAAP MEASURE, IS PROJECTED TO BE POSITIVE FOR 2018​.FY2017 REVENUE VIEW $174.0 MILLION -- THOMSON REUTERS I/B/E/S.Q4 REVENUE VIEW $45.4 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Atricure Inc Launches Atriclip Flex V Device In U.S.
Thursday, 22 Feb 2018 

Feb 22 (Reuters) - Atricure Inc ::ATRICURE INC - ‍LAUNCHES ATRICLIP FLEX•V DEVICE IN UNITED STATES​.  Full Article

Atricure Sees FY 2018 Revenue About $190 Million To $196 Million
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Atricure Inc ::FY2017 REVENUE VIEW $173.9 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $195.8 MILLION -- THOMSON REUTERS I/B/E/S.ATRICURE REPORTS PRELIMINARY RESULTS FOR FOURTH QUARTER AND FULL YEAR 2017.SEES FY 2018 REVENUE ABOUT $190 MILLION TO $196 MILLION.SEES FY 2017 REVENUE $174.7 MILLION.  Full Article

Atricure reports Q3 loss per share $0.22
Wednesday, 1 Nov 2017 

Nov 1 (Reuters) - Atricure :Atricure reports third quarter 2017 financial results.Q3 revenue $42.2 million versus I/B/E/S view $43.4 million.Q3 loss per share $0.22.Sees FY 2017 revenue up about 11 to 13 percent.Q3 earnings per share view $-0.24 -- Thomson Reuters I/B/E/S.Atricure Inc - for 2017 ‍net loss per share is projected to be in range of $0.94 to $1.04​.Atricure Inc - ‍company continues to expect positive adjusted EBITDA for full year 2018​.  Full Article